Drugs / BCG
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02324582 Background | Jun 2015 → Nov 2021 | urinary bladder cancer | Southern Illinois University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02324582 ↗ |
| Route | Other | “1 vial intravesicular BCG suspended in 50 ml preservative-free saline” NCT02324582 ↗ |